Oxford BioMedica to Present at 3rd Annual Regen Med Investor Day

23 March 2015

London, UK – 20 March 2015: Oxford BioMedica plc (“Oxford BioMedica” or “the Company”) (LSE:OXB), a leading gene and cell therapy company, announces that Dr Paul Blake, Chief Development Officer, will present at the 3rd Annual Regen Med Investor Day, being held Wednesday, March 25, 2015 in New York City.

Dr. Blake will present at 2:40pm ET / 6.40pm GMT to attending investors. During his presentation Dr. Blake will discuss Oxford BioMedica’s expertise in the clinical development and manufacturing of gene and cell therapies.

Details of the Oxford BioMedica presentation are as follows:

Event: ARM’s Regen Med Investor Day

Date: March 25, 2015

Time: 2.40pm ET / 6.40pm GMT

Location: Metropolitan Club, One East 60th Street, New York, NY 10022

At the time of the ARM Regen Med Investor Day, a live-streaming webcast of all panels and company presentations will be available at: https://www.arminvestorday.com/webcastand will be published on the event’s website shortly after the conference as well as on the company’s website in the media section: https://www.oxfordbiomedica.co.uk/webcasts-and-audio/.

– Ends –